CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Cipla USA, Inc. recalls Albuterol Sulfate

Read the official FDA notice

Published
27 Aug 2025
Units affected
20352 packs (1x 200 MD)
Agency
FDA
Country
United States

The hazard

Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Albuterol Sulfate, Inhalation Aerosol, 90 mcg, 200 metered Inhalations, NET CONTENT 6.7 g, Manufactured by: Cipla Ltd, Indore, SEZ, Pithampur, India; Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-142-60.

Brand / company
Cipla USA, Inc.
Codes / lots
Lot#: 4IB0519, Exp. 04/30/2026
Distribution
U.S. Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 27 Aug 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.